The “External radiotherapy, brachytherapy” modality comprises the following entries: 1° Entry A providing external radiotherapy treatment for adults; 2° Entry B providing brachytherapy treatment for adults; 3° Option C providing the same treatments for children and adolescents under the age of eighteen, in addition to external radiotherapy or brachytherapy treatments for adults.
Systemic drug treatments for cancer include chemotherapy, targeted therapies, immunotherapy and advanced therapy drugs, whatever the route of administration.
The “Systemic drug treatments for cancer” modality comprises the following entries: 1° Entry A providing systemic drug treatments for cancer in adults, excluding intensive chemotherapy mentioned in entry B; 2° Entry B providing, in addition to systemic drug treatments for cancer in adults, intensive chemotherapy leading to foreseeable aplasia of more than eight days and the management of this foreseeable aplasia; 3° Mention C providing systemic medicinal treatments for cancer…
Establishments are not subject to authorisation for cancer treatment when they provide: 1° Surgery to diagnose cancer; 2° For patients with an established cancer diagnosis, surgery to treat or alleviate a complication linked to the consequences of cancer or its treatment, without attempting to remove the tumour; 3° An emergency operation for another indication, leading to the discovery of a malignant tumour. The operation is then carried out without attempting…
I.- Authorisation holders for medicine, surgery, interventional radiology, medical care and rehabilitation or home hospitalisation may be associated with an authorisation holder for cancer treatment using systemic medicinal treatments. II.-Within the framework of a formalised organisation with this authorisation holder, and without being subject to the cancer treatment authorisation, these establishments may: 1° Apply systemic cancer drug treatments decided upon and first prescribed by the authorisation holder for systemic cancer…
The following are not subject to authorisation for cancer treatment: 1° Holders of an authorisation to carry out nuclear medicine or interventional radiology care activities when they carry out diagnostic or therapeutic cancer procedures related to this authorisation; 2° Health establishments or persons who participate in the local care of cancer patients in association with an authorisation holder, by providing these patients with medical and rehabilitation care or palliative care.
I.-Authorisation may only be granted if the applicant is a member of the specific regional cancer scheme recognised by the Institut national du cancer. II-The holder of the authorisation meets the accreditation criteria defined by the Institut National du Cancer in application of 2° of article L. 1415-2 with regard to the quality of cancer treatment.
Authorisation may only be granted if the applicant: 1° Has an organisation, set up where appropriate jointly with other cancer treatment authorisation holders, which ensures that each patient is informed of the diagnosis and of a therapeutic proposal based on multidisciplinary consultation in accordance with the care guidelines defined by the Institut National du Cancer in application of 2° of Article L. 1415-2 and set out in a personalised care…
I.-The holder of a B surgical oncology authorisation is responsible for organising multidisciplinary referral consultations for the purposes of making therapeutic proposals likely to include the complex surgical oncology treatments he provides. This organisation is set up, if necessary in conjunction with other holders of a B surgical oncology authorisation, without prejudice to the application of the provisions of 2° of article R. 6123-91-1. Therapeutic proposals likely to include the…
I.-Without prejudice to the application of the provisions of I of article R. 6123-91, the establishment authorised to treat cancer in children and adolescents under the age of eighteen is a member of an inter-regional paediatric oncology referral hospital organisation, identified by the Institut National du Cancer in application of article L. 1415-2. This organisation is responsible in particular for organising and providing inter-regional paediatric multidisciplinary consultation for patients under…
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
